Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jan 04, 2023

BUY
$51.49 - $81.64 $500,688 - $793,867
9,724 New
9,724 $567,000
Q2 2022

Aug 09, 2022

BUY
$51.49 - $81.64 $500,688 - $793,867
9,724 New
9,724 $567,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.1B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Virginia Wealth Management Group, Inc. Portfolio

Follow Virginia Wealth Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.